Trial Profile
Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers (A Randomized, Double- or Evaluator-blinded, Single-dose, Four-arm, Crossover Pharmacokinetics (PK) Study in Healthy Adults)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2017
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Amphastar Pharmaceuticals
- 06 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Oct 2014 New trial record